Loading clinical trials...
Loading clinical trials...
Dupilumab De-escalation in Pediatric Atopic Dermatitis: A Pilot Trial
Conditions
Interventions
Dupilumab - Discontinuation
Dupilumab - Dose Reduction
+1 more
Locations
1
United States
Johns Hopkins Univerisity
Baltimore, Maryland, United States
Start Date
April 1, 2024
Primary Completion Date
April 1, 2027
Completion Date
April 30, 2027
Last Updated
April 20, 2026
NCT06461897
NCT07262983
NCT06389136
NCT06342713
NCT07290803
NCT07223697
Lead Sponsor
Johns Hopkins University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions